Comparison of once daily dose of 0.3% nepafenac alone and three times dose of 0.1% nepafenac alone in pain and inflammation control after phacoemulsification
Indian J Ophthalmol
; 2022 Mar; 70(3): 807-812
Article
| IMSEAR
| ID: sea-224227
Texte intégral:
1
Indice:
IMSEAR
Texte intégral:
Indian J Ophthalmol
Année:
2022
Type:
Article